CNO Financial suffers $529M quarterly loss on reinsurance deal
Carmel-based insurance holding company CNO Financial Group Inc. on Wednesday reported a big third-quarter loss despite sales growth in all three of its business units.
Health Care & Insurance
Articles
Data breach at Bankers Life under investigation by state insurance department
Bankers Life and Casualty, a division of Carmel-based CNO Financial Group, said some of its customers had personal data exposed, including Social Security numbers, driver’s license numbers, bank account numbers and medical information.
Anthem boosts forecast after Q3 jump in earnings, revenue
Indianapolis-based Anthem Inc. added more Medicare customers and continued to clamp down its biggest expense, benefit payouts, in the third quarter.
U.S. Senate candidates meet in relatively calm final debate
The candidates—Joe Donnelly, Mike Braun and Lucy Brenton—were asked about foreign policy, climate change, sexual assault and immigration, but health care seemed to be the main topic Donnelly and Braun wanted to address.
NCAA, Pentagon, IU medical school broaden concussion research on student-athletes
The NCAA, which has been sued dozens of times for its role in handling concussions, will help fund an expanded $22.5 million study to examine the impacts of head injuries.
Tobacco, opioid epidemics claimed 14,200 Hoosier lives in 2017, studies say
Two reports, sponsored by the Richard M. Fairbanks Foundation, say the state should not let up in fighting twin scourges that claim thousands of lives and cost billions of dollars in health care costs and lost productivity.
Shoppers may face hard choices again on health marketplaces
Much of the insurance left on the Affordable Care Act marketplaces limits patients to narrow networks of hospitals or doctors and provides no coverage outside those networks.
Trump says new proposal will slash some U.S. drug prices
President Donald Trump said he was “taking aim at the global freeloading that forces American consumers to subsidize lower prices in foreign countries through higher prices in our country.”
Trump focusing on drug prices, high among voters’ concerns
President Donald Trump is linking the drug prices Americans complain about to one of his longstanding grievances: foreign countries the president says are taking advantage of U.S. research breakthroughs.
IU Health covets big prize, but neurosurgery practice clings to independence
Indiana University Health Physicians is setting its sights on one of the state’s last independent specialty holdouts, the neurosurgical Goodman Campbell Brain and Spine.
Purdue delays health care changes for employees’ spouses
The plan approved by Purdue trustees on Oct. 12 met widespread opposition from faculty and staff.
Opioid alternative from Lilly, Pfizer shows promise in study
The experimental drug eased arthritis pain in hard-to-treat patients without major safety concerns, a key step in creating a new class of medications that may one day offer an alternative to narcotics.
Medicare Advantage gaining popularity with lower costs, more benefits
Seema Verma, administrator for the Centers for Medicare and Medicaid Services and former health consultant to Mitch Daniels and Mike Pence, visited Indianapolis on Monday to drum up excitement for the program, which now covers about 20 million Americans.
Purdue trims working spouses from health care plan
Purdue University is joining a trend among large employers by limiting health care coverage for working spouses of the school's faculty and staff.
State study panel makes no recommendation on medical marijuana
Indiana lawmakers listened to more than three hours of testimony Thursday afternoon about whether Indiana should allow for medical marijuana usage but did not come to any consensus on the issue.
Novartis needs U.S. security nod for Endocyte under new rules
The Treasury pilot program implements broader powers Congress granted this year to the Committee on Foreign Investment in the U.S., a panel of officials who review foreign takeover of American firms and can recommend that the president block deals that threaten national security.
Endocyte’s $2.1B deal with Novartis comes after years of setbacks
The West Lafayette biotech firm’s stock traded as low as $1.41 last fall, following multiple setbacks and restructurings. But the stock had soared to $24 Thursday morning after news that it would be acquired by Novartis.
Endocyte acquisition gives Novartis key therapy—at almost 200 times its last price
One year ago, Indiana-based Endocyte Inc. bought the rights to a prostate cancer treatment for $12 million, plus future considerations. On Thursday, Novartis AG agreed to pay almost 200 times that amount to acquire Endocyte and the experimental therapy.
Novartis to acquire West Lafayette-based Endocyte for $2.1B
The deal represents a huge breakthrough for tiny Endocyte, which has about 90 employees in Indiana but has not yet launched a single product.
Indiana agency approves lower workers’ compensation rates
The agency said Indiana workers' compensation rates have been on a downward trend for several years because of fewer worker injuries and growing payrolls.